SciSparc announced that it will conduct a reverse share split of its issued and outstanding ordinary shares, no par value, at a ratio of 1-for-26. The Company’s Ordinary Shares will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on September 28, under the Company’s existing trading symbol “SPRC“. The reverse share split was approved by the Company’s shareholders at the Company’s Annual Meeting of Shareholders held on August 18 to be effected in the board of director’s discretion within approved parameters.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SPRC:
- SciSparc Announces 1-for-26 Reverse Share Split
- SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
- SciSparc engages bank to identity potential strategic transaction opportunities
- SciSparc initiates Phase 2b trial of Tourette Syndrome dandidate SCI-110
- SciSparc Announces Initiation of Randomized Phase IIb Clinical Trial of its Proprietary SCI-110 for Tourette Syndrome